OPK — OPKO HEALTH, INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 944809 ·
Last close
$1.62
Market Cap
$1.20B
52W High
$1.86
52W Low
$0.98
ADV30
5,099,443
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 65,414,000 | 42,063,000 | -31,409,000 | -53,534,000 | 1,880,250,000 | 390,220,000 | 764,076,000 |
| Jun 2026 | 163,580,000 | 80,017,000 | -25,042,000 | -8,416,000 | 1,829,453,000 | 300,761,000 | 645,287,000 |
| Mar 2026 | 124,196,000 | 45,755,000 | -51,017,000 | -54,848,000 | 1,856,796,000 | 341,881,000 | 652,186,000 |
| Dec 2025 | 148,450,000 | 64,025,000 | -38,317,000 | -31,257,000 | 1,931,944,000 | 369,074,000 | 663,985,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-125,046,000
Investing CF
$22,985,000
Financing CF
$77,945,000
CapEx
$-10,793,000
Dividends Paid
—
Buybacks
$-41,927,000
EPS Diluted TTM
$-0.19
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-2,407,488,000
Inventory
$50,601,000
Receivables
$94,922,000
ST Investments
—
EBIT TTM
$-112,042,000
Pretax Income TTM
$-159,122,000
Interest Exp TTM
$47,080,000
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$654,096,000
EBITDA
$-91,802,000
Free Cash Flow
$-265,188,256
Enterprise Value
$1,416,148,224
Total Cash
$384,036,000
Total Debt
$515,648,000
Shares Out
742,506,477
Trailing EPS
$-0.16
Book Value
$1.50
ROE
-8.9%
ROA
-5.9%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 606,879,000 | -218,985,000 | -225,680,000 | 1,931,944,000 | 663,985,000 | 1,267,959,000 | -178,542,000 |
| Dec 2024 | 713,142,000 | -273,558,000 | -53,224,000 | 2,200,212,000 | 834,764,000 | 1,365,448,000 | -183,489,000 |
| Dec 2023 | 863,495,000 | -158,057,000 | -188,863,000 | 2,011,698,000 | 622,479,000 | 1,389,219,000 | -28,197,000 |
| Dec 2022 | 1,004,196,000 | -246,124,000 | -328,405,000 | 2,167,259,000 | 605,611,000 | 1,561,648,000 | -95,189,000 |
TTM Snapshot
Revenues TTM
$587,896,000
NetIncome TTM
$-72,890,000
OpCashFlow TTM
—
Assets (Latest)
$1,829,453,000
Forward EPS
$-0.34
Max Pain — expiry 2027-01-15
max pain strike: $1.00 · spot: $1.69 · call oi: 22,790 · put oi: 997
Expected Move to 2027-01-15:
±$0.41
(23.96%) —
implied range
$1.29 –
$2.10
· ATM straddle on $1.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SLNCF | Silence Therapeutics plc | $1.22B | $6.53 | — |
| NKTR | NEKTAR THERAPEUTICS | $1.23B | $35.91 | — |
| AAPG | ASCENTAGE PHARMA GROUP INTERNATIONAL | $1.23B | $13.14 | — |
| SLN | Silence Therapeutics plc | $1.23B | $19.80 | — |
| KARD | Kardigan, Inc. | $1.23B | $13.19 | — |
News headlines (Yahoo Finance, 1h cache)
Here's Why You Should Retain OPK Stock in Your Portfolio for Now
2026-11-18 16:57 · Yahoo
Is OPKO Health (OPK) A Bargain As New Results And Guidance Reset Valuation?
2026-11-08 01:15 · Yahoo
How Investors May Respond To OPKO Health (OPK) Updated Revenue Guidance
2026-11-08 00:22 · Yahoo
OPKO Health (OPK) Q3 2026 Earnings Call Transcript
2026-11-05 15:13 · Yahoo
What OPKO Health (OPK) Said on Its Q3 Earnings Call
2026-11-05 06:14 · Yahoo
OPKO Health Inc (OPK) (Q3 2026) Earnings Call Highlights: Revenue Climbs 16% as LabCorp Deal ...
2026-11-05 05:20 · Yahoo
OPKO Health (OPK) Reports Q3 Loss, Misses Revenue Estimates
2026-11-04 23:45 · Yahoo
OPKO Health: Q3 Earnings Snapshot
2026-11-04 22:07 · Yahoo
OPKO Health Reports Third Quarter 2026 Business Highlights and Financial Results
2026-11-04 21:23 · Yahoo
Cocrystal Pharma Provides Business Update and Reports Third Quarter 2026 Financial Results
2026-11-15 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.